Clinical trial to evaluate the efficacy and safety of E-52862 ( 400 mg) by oral route, in patients with painful diabetic neuroparthy.

Registry ID

EUCTR2012-000400-14

Source registry

EUCTR

Status

Completed

Phase

PHASE2

Sponsor

Laboratorios del Dr. Esteve. S.A

Start date

2012-06-14

Last update

2026-08-16

Conditions

• painful diabetic neuropathy

Summary

The primary objective of this study is to assess the analgesic efficacy of E-52862 in subjects with moderate to severe painful diabetic neuropathy.

Locations

• , , Romania
• , , Spain

View on source registry